Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Stroke|August 6, 2025
Device-Detected Atrial Fibrillation in Patients With and Without Cryptogenic Ischemia: The ANTARCTICA Pooled AnalysisShadi Yaghi, Luciano A Sposato, Liqi Shu, et al.
JAMA Neurology|April 14, 2020
Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated StrokeAkram Y Elgendy, Jeffrey L Saver, Zahid Amin, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized TrialScott E Kasner, Pablo Lavados, Mukul Sharma, et al.
European Heart Journal|January 28, 2021
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditionsChristian Pristipino, Peter Germonpré, Danilo Toni, et al.
European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
The Lancet. Neurology|December 15, 2023
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trialMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
Neurology|May 3, 2024
Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial FeasibilityAndy Y Wang, Peter M Rothwell, Jason Nelson, et al.
The New England Journal of Medicine|May 17, 2018
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined SourceRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
European Stroke Journal|January 30, 2026
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke preventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
The New England Journal of Medicine|April 15, 2026
Asundexian for Secondary Stroke PreventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
Pageof 38